Home > Insider Trading > Filing (0001181431-13-052157)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
861838	Idera Pharmaceuticals Inc.	IDRA	Biological Products, (No Disgnostic Substances) (2836)	043072298

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1562070	Umari Abdul-Wahab	C/O Idera Pharmaceuticals, Inc. 167 Sidney Street Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-30	845,161	$0.00	0	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2013-09-30	929,032	$0.00	0	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Footnotes

On September 30, 2013, upon the consummation of a public offering of the Issuer (the "Offering"), Pillar Pharmaceuticals IV, L.P. ("Pillar IV"), of which Pillar GP is the general partner, acquired, in the Offering, 845,161 shares of common stock (the "Pillar IV Shares") of the Issuer.
On September 30, 2013, upon the consummation of the Offering, Participations Besancon ("Besancon"), a fund advised by Pillar GP, acquired, in the Offering, 929,032 shares of common stock (the "Besancon Shares").
Abdul-Wahab Umari is a director of Pillar GP and serves as the representative of a Pillar IV and Pillar GP on the Issuer's board of directors. Mr. Umari disclaims Section 16 beneficial ownership of the Pillar IV Shares and Besancon Shares and this report shall not be deemed an admission that he is the beneficial owners of any such securities, except to the extent of his pecuniary interest therein, if any, by virtue of his ownership interest in Pillar GP. As of the date hereof, Mr. Umari owns directly 58,617 shares of common stock of the Issuer.